URILES

For lowering uric acid, relieve joint pain and inflammation

A combination of Boswellin PS® extract and Ayuric® extract 

Benefits:

  • To reduce blood uric acid levels

  • To reduce swelling around the joints

  • To reduce inflammation around the joints

  • To reduce pain in inflammatory conditions

Uniqueness:

  • Standardised extracts that comply with standard herbal monograph

  • Proven safety and efficacy

  • Drug-free

  • Optimal dose in ONE easy-to-take formula

  • HALAL certifiable

Boswellia serrata (boswellin ps® )

Boswellin® PS is obtained from the gum exudate of Boswellia serrata trees commonly known as Frankincense

In addition to the active Boswellic acids, Boswellin® PS also contains 
Polysal™ which contributes to its immediate anti-inflammatory action

Terminalia Bellerica (Ayuric® )

Omegaxanthin also contains additional booster power of Astaxanthin, the "King of Antioxidants" sourced from Japanese global leading company, AstaReal  

astha website.png
astha 2.png
ast website.png

product nutritional information

product img.png

Packaging size: 60 softgel capsules 

Each 1450mg Softgel Capsule Contains:

Fish oil.................................................................1000mg

Equiv. to Eicosapentaenoic acid: 500 mg 

Equiv. to Docosapentaenoic acid: 200 mg 

Haematococcus Pluvialis Extract.......................20mg 

Equiv. to 2mg of Astaxanthin

Direction to use:

Adult: Take 1 softgel capsule once daily, after meal or as directed by pharmacist / doctor 

Indication:

Used as health supplement 

Source of capsule: Bovine 

This product contains substance derived from seafood 

Reference​:

  1. Omega-3 Fatty Acids: Fact Sheet for Health Professionals (National Institute of Health, Office of Dietary Supplements)

  2. Global Recommendations for EPA and DHA intake (Rev 16 April 2014)

  3. Ambati RR, Phang SM, Ravi S, Ashwathanarayana RG. Astaxanthin: sources, extraction, stability, biological activities and its commercial applications - a review. Mar Drugs. 2014 Jan 7;12(1):128-52

  4. Georgiou T, Neokleous A, Nikolaou D, and Sears B. Pilot study for treating dry age-related macular degenaration (AMD) with high-dose omega-3 fatty acids. PharmaNutrition 2:8-11 (2014)

  5. Inhibition of choroidal neovascularization with an anti-inflammatory carotenoid astaxanthin. Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1679-85

  6. Lee JH, Prasad A, Jarreau TK, O'Keefe JH, Milani R et al., (2011) Omega-3 Fatty Acids and Cardiovascular Disease. JMarine Sci Res Development S1:001

  7. Lu et al., (2010) Brain Res Nov 11;1360:40-8.